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Background: 
 
Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) is a rare metabolic 
disorder caused by a mutation in the thymidine phosphorylase (TP) gene, leading to 
secondary aberrations to the mitochondrial genome. The disease is clinically 
characterised by neurological and gastrointestinal dysfunctions, including neuropathy 
and leukoencephalopathy.  
 
Aims: 
 
The understanding of molecular mechanisms of MNGIE affecting the nervous system is 
hindered by the lack of a representative model. We are developing in vitro 3-D cerebral 
organoids as a neuronal model for MNGIE.  
 
Methods: 
 
Patient-derived somatic cells were reprogrammed to generate bona fide induced 
pluripotent stem cell (iPSC) lines. Pluripotent cells were differentiated into 
neuroepithelium, embedded in Matrigel and cultured in retinoic acid within bioreactors to 
generate CNS organoids. TP activity of organoids was monitored by weekly UPLC 
analysis of spent culture medium and intact organoids were sampled for morphological 
evaluations and for RNA extraction. 
 
Results: 
 
The iPSCs were positive to the immunofluorescence detection of pluripotency markers 
TRA-1-60 and SOX2. Germ layer differentiation assay indicated that iPSCs were capable 
of differentiating into Endoderm, Mesoderm and Ectoderm tissues. Karyotyping indicated 
no chromosomal abnormalities in generated lines. iPSCs successfully generated cerebral 
organoids displaying presence of neuromelanin pigments and cystic structures. Levels of 
thymidine quantified by UPLC, showed no significant changes in concentration for MNGIE 
whereas in Control organoids, levels of thymidine decreased over weeks, indicating that 
thymidine phosphorylase is active. 
 
Conclusion: 
 
We have established a neuronal organoid model of MNGIE which will be employed in 
whole genome expression profiling to investigate differential expression between MNGIE 
and Control and gene editing for the generation of a rescue phenotype. 
